Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Composition for treating pathology associated with MSRV/HERV-W

Composition for treating pathology associated with MSRV/HERV-W

US Patent 7666420 · Granted Feb 23, 2010

Estimated economic value: $128,159,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-HERV-K envelope protein antibodies and methods for detecting HERV-K envelop2021
Antiretroviral drug targeting human endogenous retrovirus2021
Compounds for treating the remyelination blockade in diseases associated with th2020
Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by ne2020
Therapeutic use of specific ligand in MSRV associated diseases2018
Immunogenic composition in emulsion form2018
Immunogenic composition in emulsion form comprising two dispersed phases, one co2018
Compounds for treating the remyelination blockade in diseases associated with th2017
Method for real-time measurement of the individual secretions of a cell2017
Therapeutic use of specific ligand in MSRV associated diseases2017
Therapeutic use of specific ligand in MSRV associated diseases2017
Therapeutic use of specific ligand in MSRV associated diseases2014